fashion -WSS

fashion

author：entertainment 2025-09-06 03:40:09 - browse：6272

A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition succeeded in its main goal in a clinical trial, the company said Monday, and also pointed to potential reductions in hospitalization and death.

The results may give the medicine, acoramidis, a path to the market after a failure that led its maker’s stock to plunge in December 2021.

In the time since the initial failure, a rival Pfizer drug has become even more entrenched and another medicine, from Alnylam Pharmaceuticals, has had a successful clinical readout in the heart disease, known as ATTR-CM, in which a defective protein leads clumps to build up in the heart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Why palliative psychiatry is worth discussing

hotspot

WSS

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Grail's uphill battle for Medicare to cover its cancer screening test

STAT readers on older presidents, polypills, Medicare, and more

Women's World Cup brings attention to abuse in soccer

New documents shed light on MD Anderson Cancer Institute feud

A new nitrogen execution bill also undermines medical licensing

focus

fashion

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

With competition flaring, obesity drug hits goal in liver disease study

The cancer drug shortage isn’t new — and neither are the solutions

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Drug repurposing or repositioning? The language matters

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Apple is now the first public company to be valued at $3 trillion

Alabama frozen embryo ruling has major implications for IVF clinics

hotspot

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Superbugs, antibiotic resistance get scrutiny in congress

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

A new nitrogen execution bill also undermines medical licensing

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Alabama frozen embryo ruling has major implications for IVF clinics

explore

leisure time

hotspot

explore